Crinetics Pharmaceuticals (CRNX) Enterprise Value
Price: $30.42
Market Cap: $2.83B
Avg Volume: 1.03M
Market Cap: $2.83B
Avg Volume: 1.03M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Crinetics Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 4.47B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 4.13B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $51.13, with 91.49M shares outstanding.
- The company has 264.55M in cash and cash equivalents and 51.72M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$4.47B
Market Cap
$4.68B
Total Debt
$51.72M
Cash and Equivalents
$264.55M
Historical Enterprise Value
Crinetics Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $4.47B | 16.65% | $51.13 | 91.49M | $4.68B | $264.55M | $51.72M |
| September 30, 2024 | $3.83B | 12.88% | $51.1 | 80.09M | $4.09B | $317.27M | $52.54M |
| June 30, 2024 | $3.39B | 12.28% | $46.07 | 79.01M | $3.64B | $302.16M | $53.32M |
| March 31, 2024 | $3.02B | 26.59% | $46.53 | 72.29M | $3.36B | $395.92M | $52.50M |
| December 31, 2023 | $2.39B | 49.23% | $35.58 | 67.15M | $2.39B | $54.90M | $51.73M |
| September 30, 2023 | $1.60B | 69.90% | $29.74 | 56.81M | $1.69B | $142.79M | $52.17M |
| June 30, 2023 | $941.05M | 13.74% | $18.02 | 54.27M | $978.04M | $39.55M | $2.56M |
| March 31, 2023 | $827.39M | -13.33% | $16.06 | 53.91M | $865.76M | $41.19M | $2.82M |
| December 31, 2022 | $954.61M | -7.18% | $18.3 | 53.84M | $985.25M | $32.67M | $2.02M |
| September 30, 2022 | $1.03B | 11.81% | $19.64 | 53.77M | $1.06B | $30.91M | $3.32M |
| June 30, 2022 | $919.81M | 2.38% | $18.65 | 52.52M | $979.54M | $62.29M | $2.56M |
| March 31, 2022 | $898.46M | -17.37% | $21.95 | 47.43M | $1.04B | $145.55M | $2.82M |
| December 31, 2021 | $1.09B | 67.75% | $28.41 | 45.23M | $1.28B | $200.69M | $3.07M |
| September 30, 2021 | $648.19M | 23.85% | $21.05 | 38.31M | $806.40M | $161.54M | $3.32M |
| June 30, 2021 | $523.39M | 29.99% | $18.85 | 37.06M | $698.60M | $178.77M | $3.56M |
| March 31, 2021 | $402.63M | 7.12% | $15.28 | 33.01M | $504.42M | $105.58M | $3.79M |
| December 31, 2020 | $375.88M | -6.45% | $14.11 | 32.95M | $464.95M | $93.09M | $4.01M |
| September 30, 2020 | $401.80M | 2.00% | $15.67 | 32.89M | $515.39M | $117.82M | $4.23M |
| June 30, 2020 | $393.92M | 25.57% | $17.52 | 31.41M | $550.29M | $160.81M | $4.44M |
| March 31, 2020 | $313.70M | -45.21% | $14.7 | 24.49M | $359.97M | $50.92M | $4.65M |
| December 31, 2019 | $572.58M | 88.81% | $25.09 | 24.23M | $608.06M | $40.33M | $4.85M |
| September 30, 2019 | $303.25M | -44.91% | $15.04 | 24.21M | $364.09M | $66.58M | $5.74M |
| June 30, 2019 | $550.45M | 12.85% | $25.01 | 24.16M | $604.27M | $59.72M | $5.90M |
| March 31, 2019 | $487.78M | -27.86% | $22.6 | 24.09M | $544.55M | $62.83M | $6.07M |
| December 31, 2018 | $676.17M | 77.66% | $29.99 | 24.05M | $721.14M | $44.97M | $- |
| September 30, 2018 | $380.59M | -19.20% | $27.49 | 20.02M | $550.24M | $169.65M | $- |
| June 30, 2018 | $471.01M | 1.15% | $24.51 | 22.01M | $539.42M | $68.41M | $- |
| March 31, 2018 | $465.68M | 42.86% | $24.51 | 22.01M | $539.42M | $73.74M | $- |
| December 31, 2017 | $325.96M | -4.17% | $24.51 | 13.88M | $340.15M | $14.19M | $- |
| September 30, 2017 | $340.15M | 0.00% | $24.51 | 13.88M | $340.15M | $- | $- |
| June 30, 2017 | $340.15M | -3.45% | $24.51 | 13.88M | $340.15M | $- | $- |
| March 31, 2017 | $352.31M | - | $24.51 | 13.88M | $340.15M | $-12.15M | $- |
Related Metrics
Explore detailed financial metrics and analysis for CRNX.